Bayer Showcases Nearly 30 Debuts at CIIE
The German drugmaker and agribusiness is exhibiting at the ninth China International Import Expo in Shanghai as it marks nine consecutive years of full attendance.
Updated on Nov. 5, 2026 in Healthcare
Live Poll
Do you trust large drugmakers to bring useful new medicines to everyday people?
Bayer is attending the ninth China International Import Expo in Shanghai, bringing its Pharmaceuticals, Consumer Health and Crop Science divisions. The company is presenting nearly 30 debuts spanning disease treatment, precision diagnostics, self-care and agriculture.
Why it matters
The expo gives Bayer a platform to introduce global innovations to the Chinese market while drawing on local insights into its global research network. Its sustained presence reflects the importance of China as a major healthcare and agricultural market for multinational companies.
Bayer has attended the CIIE in full for nine consecutive years and is presenting nearly 30 debuts this year. The source does not disclose revenue projections or sales targets tied to the China launches.
The players
Bayer
Bayer is a German multinational life sciences company with operations in pharmaceuticals, consumer health and crop science, with a history spanning more than 160 years.
The details
Bayer is showcasing products across two locations at the expo, Booth A3-03 in Hall 1.1 and Booth B3-02 in Hall 8.1, within the Medical Equipment and Healthcare Products and Food and Agricultural Products exhibition areas. The company is accelerating the introduction of global innovations to China through the CIIE.
Timeline
November 5, 2026: The ninth CIIE opened in Shanghai with Bayer in attendance.
2027: Bayer marks 145 years of presence in China.
Market Landscape
Bayer's nine consecutive years of full CIIE attendance places it among multinational firms using the expo as a recurring channel into China's healthcare and agricultural markets. Its 145-year presence in China, marked next year, underscores a long-running commercial footprint that the expo continues to reinforce.
Consumers in China may gain access to Bayer's newly debuted pharmaceutical, consumer health and crop science products as they reach the market. The source does not specify availability dates or pricing for individual products.
The takeaway
Multinational healthcare companies are treating trade expos like the CIIE as a sustained route for introducing global innovations and gathering local insight. Readers tracking the sector can watch whether debuted products reach Chinese patients and farms on announced timelines.
Further reading
For more on how multinational drugmakers are approaching the sector, see Healthcare.
Source note: This article includes information reported by China Daily.
Live Poll
Do you trust large drugmakers to bring useful new medicines to everyday people?
